Top Markets
Coin of the day
DocMorris AG DocMorris AG

DocMorris AG

DOCM
Peringkat dalam Saham #11450
DocMorris AG is a key player in the pharmaceutical sector, focusing on both... DocMorris AG is a key player in the pharmaceutical sector, focusing on both online pharmacy services and the wholesale supply of medical and pharmaceutical goods. The company provides a comprehensive selection of items, including prescription and over-the-counter medications, health and wellness products, beauty and personal care lines, dietary supplements, pain relief remedies, and emergency first aid supplies. Furthermore, it offers specialized medication management support. In addition to its significant digital footprint, DocMorris AG also operates traditional brick-and-mortar pharmacy locations. Its commercial activities extend across Switzerland and into various international territories, serving medical practitioners, other online pharmaceutical distributors, and individual consumers directly. Notable brands within its portfolio include Zur Rose, PromoFarma, TeleClinic, and DocMorris. Established in 1993 and based in Frauenfeld, Switzerland, the company adopted its current name, DocMorris AG, in May 2023, having previously been known as Zur Rose Group AG.
Harga Saham
$14.31
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$699.41M
Perubahan (1 hari)
3.38%
Perubahan (1 tahun)
73.52%
Negara
CH
Perdagangan DocMorris AG (DOCM)

Kategori

Laba untuk DocMorris AG (DOCM)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari DocMorris AG, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk DocMorris AG dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$6.46B -
US
- -
US
$2.17B -
US
- -
US
$708.86M -
AU